DOCSLIB.ORG

A4-Idetna Catalog 2021-Update-V2.Cdr

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A4-Idetna Catalog 2021-Update-V2.Cdr IIDDeennttaa World Leader in Forensic Products 2021 CATALOG Where Shifting Threats Meet Solutions www.identa-corp.com www.touch-know.com IIDDeennttaa World Leader in Forensic Products DON'T STAY BEHIND Corporate Headquarters: Bethlehem Road 120 Jerusalem 9342001 Israel Tel: +972 2-5872220 E-mail: [email protected] Drug Detection & Identi4cation IIDDeennttaa About Us Our Product Line World Leader in Forensic Products IDenta Corporation is a leading detection and IDenta’s product line offers the latest scientific forensic science company. We use the latest advances in an easy-to-use, rugged and durable in science and technology to provide solutions packaging. Our testing kits can be used in to law enforcement agencies, military, extreme temperature conditions and have a government agencies and other organizations long shelf life. dealing with the demanding and constantly changing challenges of fighting illicit drug Our innovative CUSPER casing comes with crimes and terrorist threats globally. four different sampler types providing a complete solution for various needs anywhere IDenta leads the industry with the latest in and anytime. on-the-spot field-testing kits for the identification of illicit drugs, precursors of Our kits can test any substances, including drugs and explosives, as well as a bullet traces in the microgram to nanogram range, hole testing kit. We continually research and on both small and very large surfaces; when develop additional forensic solutions. used in combination with the AeroChamber Sniffer tool. The kits can be used to detect IDenta’s products are used by law enforcement trace amounts of dangerous or illicit chemicals agencies around the globe, including: USA, on persons, surfaces and clothing. IDenta’s United Nations, Germany, France, Italy, kits can also be used to test liquids. Spain, Israel, Indonesia, Brazil, Mexico, South Africa, Nigeria, and Canada among others. Our patented technology does not require The company also supplies leading military the user to have direct physical contact with agencies operating in challenging conditions suspect substances and the sampler is protected with customized rugged solutions. from any possible contamination. IDenta's Chief Scientist and founder, Mr. Baruch Glattstein is a retired Chief Superintendent of the Israeli Police Forensic Science Division and a former R&D Officer in the Chemistry division. Mr. Glattstein has an international reputation for his versatility and success as a top researcher and developer of forensic science. IDenta 3 IIDDeennttaa World Leader in Forensic Products Contents AeroChamber Sniffer for Drug Explosive Drugs/Explosives Cusper Detection Detection & Detection Bullet Hole Consumer & Testing Device & Identification Identification & Identification Testing Kit Retail Products 5 7 23 30 36 43 5 Key Features 8 Key Features 24 Key Features 31 Key Features 37 Key Features 43 Touch & Know 6 CUSPER Probes 9 Drug Detection 25 CUSPER Alert 32 Components 38 Suitcase 9 Kits 25 Series 38 Contents 33 Suitcase 19 Precursors of 26 Explosive 33 Contents 39 Components 19 Drugs Detection 26 Detection 33 and Kits 19 Kits 26 Kits 21 Suitcases 29 Suitcase and Additional 22 Additional Products 22 Products IDenta 4 Introducing the CUSPER - a revolutionary advancement in the field of drug and explosive screening and identification. The CUSPER test kit provides the perfect alternative to tests that are outdated, dangerous, A Revolutionary Advancement complicated and complex tests. in Forensic Testing The CUSPER offers a major breakthrough: IDenta's patented casing technology combined with advanced chemistry creating the most reliable and accurate test kits on the market. IDenta’s CUSPER features: Safety: ■ Rugged plastic casing ■ Safe to use – no direct contact with the substance or chemicals ■ Self-contained, closed system ■ Safe to dispose – built-in neutralizing ■ 4 different samplers (probes) available ■ Maximum protection from accidental ■ The sampler is protected from any possible breakage contamination ■ Easy to use ■ Tests substances, traces, all size surfaces, people and liquids ■The adhesive surface of the sampler takes the exact amount of substance needed ■ Long shelf life; no storage restriction from any surface ■ Operates in extreme temperatures ■ Fits in your pocket Steps: 1 2 3 4 5 A color change Touch or swipe indicates the presumed the probe to the Lock the probe Squeeze the Gently shake presence of the suspect substance into the reaction reagent capsules on the unit to start substance with or surface chamber the back of the unit the reaction extreme accuracy IDenta 5 A Revolutionary Advancement CUSPER Probes Effective On in Forensic Testing Pills, CUSPERTouch Tablets and t e s t s v i s i b l e Capsules materials such as tablets or Powders and s u b s t a n c e s Crystals CUSPERSwipe Organic Material s u s p e c t e d s u r f a c e s a m p l i n g Liquids CUSPER Sniffer works with our AeroChamber for large surfaces, people and more IDenta 6 IIDDeennttaa World Leader in Forensic Products On-the-spot drug testing has just become SAFE, SIMPLE AND ACCURATE. IDenta’s Drug Detection and Identification test kits offer breakthrough innovations long awaited by the forensic market. Until recently, only difficult to use and hard to understand test kits with many constraints and limitations were available. IDenta’s kits make the tasks faced by parents, educators, employers and law enforcement officers easier, faster, far safer and more cost effective than any similar kit available. Key Benefits: Key Markets: ■ Easy, fast and simple to use! No other tests are ■ Law enforcement as straightforward. ■ Military ■ Accurate and reliable at extreme temperatures. ■ Customs ■ Clear results in seconds. ■ Security agencies ■ Long shelf life (up to 3 years) with no storage ■ Government agencies restrictions. - DEA / FBI / CIA ■ Safe. Actually, very safe. No contact with ■ Prisons chemicals or substances. No inhalation of vapors, no protective gear needed. ■ Corporate HR departments ■ Safe to dispose. Self-contained neutralization. ■ Private residences ■ Small and very rugged. ■ Schools / Universities ■ Can be used anywhere, anytime. ■ Rehabilitation facilities ■ Available with various probes: ■ Border control Touch, Swipe, Sniffer or Sampler. ■ Emergency rooms ■ Our kits DO test liquids. ■ Can test large surfaces. ■ Wide selection of CUSPER testing kits available from general drug screening to specific drugs, designer drugs as well as precursors of drugs. ■ Latest advanced "bath salts" / designer drug testing capabilities. 8 Drug Detection & Identification / Popular Tests # IDT1000T # IDT1100 # IDT2000T Cocaine/Crack Cocaine/Crack White Heroin Identification Confirmation Identification Field Test Kit Field Test Kit Field Test Kit ■ The color test is based on modified Scott ■ The Scott Reagent, as a single reagent, cannot ■ The color test is based on modified Marquis Reagent. really serve as a specific color reaction for the Reagent. ■ The kit can test substances, liquids, and identification of cocaine. False positive results ■ Traces can be tested with the swipe sampler. This traces on any suspect surface. can occur with substances that have similar is the first time suspected surfaces can be tested response characteristics. ■ The sampler can sample small surfaces and using the Marquis Reagent. even hands. ■ Cocaine/Crack Confirmation test discriminates ■ The kit tests substances and traces on any suspect cocaine and its salts from substances that ■ Testing large surfaces - clothing, packages, surface, including small surfaces and hands. falsely give a positive color reaction with Scott's or a vehicle - can be easily sampled by the Reagent (IDenta Patent). ■ Even one particle of 0.1 mm white heroin Sniffer AeroChamber (pages 28-33). produces a visible result. ■ The test distinguishes between cocaine and ■ Even one particle of 0.1 mm of cocaine or crack as well. ■ Once the test is finished, the casing has a self- crack produces a visible result. contained neutralization reagent. ■ The kit tests substances and liquids, but is ■ Further confirmation of is possible, even with not intended for traces. traces, since the test is nondestructive. The test kit can be sent to a drug testing lab. 9 Drug Detection & Identification / Popular Tests MIX Heroin Heroin Black Tar Opiates Identification Identification Identification IDenta IDenta IDenta # IDT2100T # IDT2200 # IDT2300 # IDT2400T Brown Heroin Mix Heroin Heroin Black Tar Opiates Identification Identification Identification Identification Field Test Kit Field Test Kit Field Test Kit Field Test Kit ■ Brown heroin is usually 5-20% heroin and ■ This mix kit is a combination of the popular ■ Black tar can contain a variable percentage of ■ The color test is based on modified Marquis contains a mixture of alkaloids and adulterants. brown heroin and white heroin tests. heroin. Reagent. ■ IDenta’s novel kit detects heroin even if the ■ The kit offers two testing options in order to ■ It is typically found as a sticky black substance. ■ The kit contains a novel sampler for sampling presence of heroin is only 5%. (IDenta Patent). identify either type of heroin as well as ■ The color test is based on the Marquis Reagent. rigid tablets. opiates. ■ The kit tests substances and traces on any ■ The kit contains a novel sampler for sampling suspect surface. ■ Brown heroin is usually found as a brown ■ The reagent contains strong acid and IDenta the sticky black substance. has the only safe kit for the user. Health and ■
Load more

Recommended publications
  • Analysis of Drugs Manual September 2019
    Drug Enforcement Administration Office of Forensic Sciences Analysis of Drugs Manual September 2019 Date Posted: 10/23/2019 Analysis of Drugs Manual Revision: 4 Issue Date: September 5, 2019 Effective Date: September 9, 2019 Approved By: Nelson A. Santos Table of Contents CHAPTER 1 – QUALITY ASSURANCE ......................................................................... 3 CHAPTER 2 – EVIDENCE ANALYSIS ......................................................................... 93 CHAPTER 3 – FIELD ASSISTANCE .......................................................................... 165 CHAPTER 4 – FINGERPRINT AND SPECIAL PROGRAMS ..................................... 179 Appendix 1A – Definitions ........................................................................................... 202 Appendix 1B – Acronyms and Abbreviations .............................................................. 211 Appendix 1C – Instrument Maintenance Schedule ..................................................... 218 Appendix 1D – Color Test Reagent Preparation and Procedures ............................... 224 Appendix 1E – Crystal and Precipitate Test Reagent Preparation and Procedures .... 241 Appendix 1F – Thin Layer Chromatography................................................................ 250 Appendix 1G – Qualitative Method Modifications ........................................................ 254 Appendix 1H – Analytical Supplies and Services ........................................................ 256 Appendix 2A – Random Sampling Procedures
    [Show full text]
  • Screening/Spot Test of Narcotics
    Indian Journal of Forensic and Community Medicine 2020;7(4):160–165 Content available at: https://www.ipinnovative.com/open-access-journals Indian Journal of Forensic and Community Medicine Journal homepage: https://www.ipinnovative.com/journals/IJFCM Review Article Screening/spot test of narcotics A K Jaiswal1,*, Kamna Sharma2, Rohit Kanojia3, Sally Lukose4 1Dept. of Forensic Medicine & Toxicology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 2Galgotias University, Greater Noida, Uttar Pradesh, India 3Dept. of Chemistry, University of Delhi, New Delhi, India 4CTM-IRTE, Faridabad, Haryana, India ARTICLEINFO ABSTRACT Article history: Narcotics are the substances used to treat moderate to severe pain. They could be natural like opiates such Received 25-11-2020 as morphine, codeine etc., synthetic like fentanyl, methadone etc., and semi-synthetic like oxycodone, Accepted 02-12-2020 hydrocodone etc. These drugs act as pain relievers, induces the state of stupor or sleep, and increase Available online 08-01-2021 the physical dependence on them. In forensic autopsy case, the forensic pathologist may require a complete toxicological investigation for different poisons including stimulants. In India, Forensic Science Laboratories run by Government under the Home ministry usually carry out this. The samples must be Keywords: analysed by the forensic toxicologist/chemists/scientist. This article deals with the screening/spot test for Narcotics narcotics. It attempts to simplify the standard procedures in a step-wise manner, which can be of handy Screening reference for the forensic toxicologist. Spot test Drugs © This is an open access article distributed under the terms of the Creative Commons Attribution Opioids etc License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • 2016 Bill No. CS for SB 1528 Ì460300XÎ460300
    Florida Senate - 2016 PROPOSED COMMITTEE SUBSTITUTE Bill No. CS for SB 1528 460300 Ì460300XÎ 576-03397-16 Proposed Committee Substitute by the Committee on Appropriations (Appropriations Subcommittee on Criminal and Civil Justice) 1 A bill to be entitled 2 An act relating to illicit drugs; amending s. 893.02, 3 F.S.; defining terms; deleting a definition; revising 4 definitions; amending s. 893.03, F.S.; providing that 5 class designation is a way to reference scheduled 6 controlled substances; adding, deleting, and revising 7 the list of Schedule I controlled substances; revising 8 the list of Schedule III anabolic steroids; amending 9 s. 893.033, F.S.; adding, deleting, and revising the 10 list of precursor and essential chemicals; amending s. 11 893.0356, F.S.; defining the term “substantially 12 similar”; deleting the term “potential for abuse”; 13 requiring that a controlled substance analog be 14 treated as the highest scheduled controlled substance 15 of which it is an analog; amending s. 893.13, F.S.; 16 creating a noncriminal penalty for selling, 17 manufacturing, or delivering, or possessing with 18 intent to sell, manufacture, or deliver any unlawful 19 controlled substance in, on, or near an assisted 20 living facility; creating a criminal penalty for a 21 person 18 years of age or older who delivers to a 22 person younger than 18 years of age any illegal 23 controlled substance, who uses or hires a person 24 younger than 18 years of age in the sale or delivery 25 of such substance, or who uses a person younger than 26 18 years of age to assist in avoiding detection for 27 specified violations; deleting a criminal penalty for Page 1 of 197 2/12/2016 8:29:32 AM Florida Senate - 2016 PROPOSED COMMITTEE SUBSTITUTE Bill No.
    [Show full text]
  • Mandelin Reagent Instructions 1
    MANDELIN REAGENT INSTRUCTIONS 1. Carefully shake bottle before each use. Open the WIM Scientific Laboratories Mandelin Reagent's factory seal. 2. Using the provided mini tester spoon, place at least .010 to .005 Grams (Tiny amount) of the questionable substance into the empty testing vial. 3. Add one or two drops of the Mandelin Reagent into the testing vial. The mandelin reagent is a strong yellow color.* 4. Watch carefully during the reaction time for color changes, any fizzing or smoking. 5. Refer to the color chart (on back) to determine what is present in the sample. 6. Rinse testing vial and the mini tester spoon thoroughly with soap and water after testing. 7. After successfully testing your substance, mini testing spoon and testing vial will need to be completely cleaned and dried before your next use. 8. After testing, the Mandelin Reagent bottle cap should be closed tightly and placed back into the bag to ensure no leakage or unwanted exposure occurs. 9. Also included are glow sticks and wristbands...because we love you. They may come in handy! Mandelin Reagent Kits are made to order with manufacture dates stamped on the bag and will be useful for at least 3-6 months depending on proper storage. Keep out of direct sunlight and hot temperatures (Above 120 degrees) for best results and lasting usage. Please note that a positive or negative reaction for any substance tested does not mean that a substance is safe. No chemical use is 100% safe. This will simply test for the presence of certain substances.
    [Show full text]
  • For Peer Review 19 Studies
    Drug Testing and Analysis A review of chemical ‘spot’ tests: a presumptive illicit drug identification technique Journal:For Drug Peer Testing and Analysis Review Manuscript ID DTA-17-0289.R1 Wiley - Manuscript type: Review Date Submitted by the Author: n/a Complete List of Authors: Philp, Morgan; University of Technology Sydney, Centre for Forensic Science Fu, Shanlin; University of Technology Sydney, Centre for Forensic Science presumptive identification, color test, new psychoactive substances, Keywords: chemistry Chemical ‘spot’ tests are a presumptive illicit drug identification technique commonly used by law enforcement, border security personnel, and forensic laboratories. The simplicity, low cost and rapid results afforded by these tests make them particularly attractive for presumptive identification globally. In this paper, we review the development of these long- established methods and discuss color test recommendations and guidelines. A search of the scientific literature revealed the chemical Abstract: reactions occurring in many color tests are either not actively investigated or reported as unknown. Today, color tests face many challenges, from the appearance of new psychoactive substances to concerns regarding selectivity, sensitivity, and safety. Advances in technology have seen color test reagents used in digital image color analysis, solid sensors and microfluidic devices for illicit drug detection. This review aims to summarize current research and suggest the future of presumptive color testing. http://mc.manuscriptcentral.com/dta Page 1 of 34 Drug Testing and Analysis 1 2 3 A review of chemical ‘spot’ tests: a presumptive illicit drug identification 4 5 technique 6 7 Morgan Philp and Shanlin Fu 8 9 10 11 Short title: Review of chemical spot tests for illicit drug detection 12 13 Chemical ‘spot’ tests are a presumptive illicit drug identification technique commonly used 14 by law enforcement, border security personnel, and forensic laboratories.
    [Show full text]
  • (12) United States Patent (10) Patent N0.: US 6,310,270 B1 Huang Et Al
    US006310270B1 (12) United States Patent (10) Patent N0.: US 6,310,270 B1 Huang et al. (45) Date of Patent: Oct. 30, 2001 (54) ENDOTHELIAL NOS KNOCKOUT MICE Benrath, J. et al., “Substance P and nitric oxide mediate AND METHODS OF USE Wound healing of ultraviolet photodamaged rat skin: evi dence for an effect of nitric oxide on keratinocyte prolifera (75) Inventors: Paul L. Huang, Boston; Mark C. tion,” Nerosci. Letts. 200.'17—20 (Nov. 1995). Fishman, Newton Center; Michael A. Boeckxstaens, G.E. et al., “Evidence for nitric oxide as Moskowitz, Belmont, all of MA (US) mediator of non—adrenergic, non—cholinergic relaxations induced by ATP and GABA in the canine gut,” Br J. (73) Assignee: The General Hospital Corporation, Pharmacol. 102:434—438 (1991). Boston, MA (US) Bohme, G.A. et al., “Possible involvement of nitric oxide in ( * ) Notice: Subject to any disclaimer, the term of this long—term potentiation,” Eur J. Pharmacol. 199:379—381 patent is extended or adjusted under 35 (1991). U.S.C. 154(b) by 0 days. Booth, R.F.G. et al., “Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular (21) Appl. No.: 08/818,082 manipulation,” Atherosclerosis 76.'257—268 (1989). Bredt, D.S. et al., “Localization of nitric oxide synthase (22) Filed: Mar. 14, 1997 indicating a neural role for nitric oxide,” Nature Related US. Application Data 347:768—770. (60) Provisional application No. 60/027,362, ?led on Sep. 18, Bredt, D.S. and Snyder, S.H., “Isolation of nitric oxide 1996, and provisional application No.
    [Show full text]
  • Nitric Oxide Synthase Inhibitors As Antidepressants
    Pharmaceuticals 2010, 3, 273-299; doi:10.3390/ph3010273 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review Nitric Oxide Synthase Inhibitors as Antidepressants Gregers Wegener 1,* and Vallo Volke 2 1 Centre for Psychiatric Research, University of Aarhus, Skovagervej 2, DK-8240 Risskov, Denmark 2 Department of Physiology, University of Tartu, Ravila 19, EE-70111 Tartu, Estonia; E-Mail: [email protected] (V.V.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +4577893524; Fax: +4577893549. Received: 10 November 2009; in revised form: 7 January 2010 / Accepted: 19 January 2010 / Published: 20 January 2010 Abstract: Affective and anxiety disorders are widely distributed disorders with severe social and economic effects. Evidence is emphatic that effective treatment helps to restore function and quality of life. Due to the action of most modern antidepressant drugs, serotonergic mechanisms have traditionally been suggested to play major roles in the pathophysiology of mood and stress-related disorders. However, a few clinical and several pre-clinical studies, strongly suggest involvement of the nitric oxide (NO) signaling pathway in these disorders. Moreover, several of the conventional neurotransmitters, including serotonin, glutamate and GABA, are intimately regulated by NO, and distinct classes of antidepressants have been found to modulate the hippocampal NO level in vivo. The NO system is therefore a potential target for antidepressant and anxiolytic drug action in acute therapy as well as in prophylaxis. This paper reviews the effect of drugs modulating NO synthesis in anxiety and depression. Keywords: nitric oxide; antidepressants; psychiatry; depression; anxiety 1. Introduction Recent data from Denmark and Europe [1,2], indicate that brain disorders account for 12% of all direct costs in the Danish health system and 9% of the total drug consumption was used for treatment of brain diseases.
    [Show full text]
  • 7-Nitro Indazole, a Selective Neuronal Nitric Oxide Synthase Inhibitor in Vivo, Impairs Spatial Learning in The
    Downloaded from learnmem.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press RESEARCH 7-Nitro Indazole, a Selective Neuronal Nitric Oxide Synthase Inhibitor in Vivo, Impairs Spatial Learning in the Rat Christian H61scher, 1'3 Liam McGlinchey, 1 Roger Anwyl, 2 and Michael J. Rowan ~Department of Pharmacology and Therapeutics and 2Department of Physiology Trinity College Dublin 2, Republic of Ireland Abstract Introduction Nitric oxide (NO) is an intercellular messen- Nitric oxide (NO) is an intercellular ger that plays a role in many physiological systems. messenger that has been suggested to have In the nervous system, NO acts as a neurotrans- a role in learning and memory formation. mitter (Amir 1992). The enzyme NO synthase Previous studies with nonselective NO (NOS) has been found in neurons (Bredt and Sny- synthase inhibitors have produced der 1992; Vincent and Kimura 1992), and endog- contradictory results in learning enous NO production occurs in neuronal cultures experiments. However, these drugs also (Ma et al. 1991). At least three isoforms of NOS produced blood pressure changes, as NO is have been identified. NOS isoform I is found in an endothelial-derived relaxing factor. A neurons, whereas isoform III has been purified novel NO synthase inhibitor, 7-nitro from endothelial cells (Schmidt et al. 1992). Both indazole (7-NI), as a dose (30 mg/kg i.p.) isoforms are Ca 2+ dependent (Moncada and shown previously to inhibit neuronal NO Palmer 1992). Isoform type II is inducible and synthase by 85% without affecting blood Ca 2+ independent. It is found in most tissues of pressure, produced amnesic effects both in the body (Kilbourn 1991; Nathan 1991).
    [Show full text]
  • This List Was Originally Published in Virginia Register Volume 8, Issue 18
    In accordance with 6 VAC 40-30, the Regulations for the Approval of Field Tests for Detection of Drugs, and under the authority of the Code of Virginia, the following field tests for detection of drugs are approved field tests: O D V INCORPORATED 13386 INTERNATIONAL PARKWAY JACKSONVILLE, FLORIDA 32218-2383 ODV NarcoPouch Drug or Drug Type: Manufacturer’s Field Test: Heroin 902 – Marquis Reagent Amphetamine 902 – Marquis Reagent Methamphetamine 902 – Marquis Reagent 3,4–Methylenedioxymethamphetamine (MDMA) 902 – Marquis Reagent Cocaine Hydrochloride 904 or 904B – Cocaine HCl and Base Reagent Cocaine Base 904 or 904B – Cocaine HCl and Base Reagent Barbiturates 905 – Dille-Koppanyi Reagent Lysergic Acid Diethylamide (LSD) 907 – Ehrlich’s (Modified) Reagent Marijuana 908 – Duquenois – Levine Reagent Hashish Oil 908 – Duquenois – Levine Reagent Marijuana 909 – K N Reagent Hashish Oil 909 – K N Reagent Phencyclidine (PCP) 914 – PCP Methaqualone Reagent Heroin 922 – Opiates Reagent Methamphetamine 923 – Methamphetamine/Ecstasy Reagent 3,4–Methylenedioxymethamphetamine (MDMA) 923 – Methamphetamine/Ecstasy Reagent Heroin 924 – Mecke’s (Modified) Reagent Diazepam 925 – Valium/Ketamine Reagent Ketamine 925 – Valium/Ketamine Reagent Ephedrine 927 – Ephedrine Reagent gamma – Hydroxybutyrate (GHB) 928 – GHB Reagent ODV NarcoTest Drug or Drug Type: Manufacturer’s Field Test: Heroin 7602 – Marquis Reagent Amphetamine 7602 – Marquis Reagent Methamphetamine 7602 – Marquis Reagent 3,4–Methylenedioxymethamphetamine (MDMA) 7602 – Marquis Reagent Barbiturates
    [Show full text]
  • Cgmp Signaling and Vascular Smooth Muscle Cell Plasticity
    Journal of Cardiovascular Development and Disease Review cGMP Signaling and Vascular Smooth Muscle Cell Plasticity Moritz Lehners †, Hyazinth Dobrowinski †, Susanne Feil and Robert Feil * ID Interfaculty Institute of Biochemistry, University of Tübingen, 72076 Tübingen, Germany; [email protected] (M.L.); [email protected] (H.D.); [email protected] (S.F.) * Correspondence: [email protected]; Tel.: +49-7071-2973350 † These authors contributed equally to this work. Received: 14 March 2018; Accepted: 16 April 2018; Published: 19 April 2018 Abstract: Cyclic GMP regulates multiple cell types and functions of the cardiovascular system. This review summarizes the effects of cGMP on the growth and survival of vascular smooth muscle cells (VSMCs), which display remarkable phenotypic plasticity during the development of vascular diseases, such as atherosclerosis. Recent studies have shown that VSMCs contribute to the development of atherosclerotic plaques by clonal expansion and transdifferentiation to macrophage-like cells. VSMCs express a variety of cGMP generators and effectors, including NO-sensitive guanylyl cyclase (NO-GC) and cGMP-dependent protein kinase type I (cGKI), respectively. According to the traditional view, cGMP inhibits VSMC proliferation, but this concept has been challenged by recent findings supporting a stimulatory effect of the NO-cGMP-cGKI axis on VSMC growth. Here, we summarize the relevant studies with a focus on VSMC growth regulation by the NO-cGMP-cGKI pathway in cultured VSMCs and mouse models of atherosclerosis, restenosis, and angiogenesis. We discuss potential reasons for inconsistent results, such as the use of genetic versus pharmacological approaches and primary versus subcultured cells. We also explore how modern methods for cGMP imaging and cell tracking could help to improve our understanding of cGMP’s role in vascular plasticity.
    [Show full text]
  • 7-Nitro Inctazole, an Inhibitor of Neuronal Nitric Oxide Synthase, Attenuates Pilocarpine-Induced Seizures
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Erasmus University Digital Repository eJp ELSEVIER European Journal of Pharmacology287 (1995) 211-213 Short communication 7-Nitro inctazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures Redmer Van Leeuwen, Ren6 De Vries, Mihailo R. Dzoljic * Department of Pharmacology, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, Netherlands Received 26 June 1995; revised 9 October 1995; accepted 13 October 1995 Abstract 7-Nitro indazole (25-100 mg/kg i.p.), an inhibitor of neuronal nitric oxide (NO) synthase, attenuated the severity of pilocarpine (300 mg/kg i.p.)-induced seizures in mice. This indicates that the decreased neuroexcitability of the central nervous system (CNS) following administration of 7-nitro indazole may be due to inhibition of neuronal NO synthase, implying that NO acts as an excitatory and proconvulsant factor in the CNS. Keywords: Epilepsy; Nitric oxide (NO); Nitric oxide (NO) synthase; 7-Nitro indazole; Pilocarpine; Seizure 1. Introduction nine), potentiated seizures induced in rats by various convulsant compounds, such as quinolinate (Haberny As a retrograde messenger, nitric oxide (NO) in- et al., 1992), kainic acid (Rondouin et al., 1993) and duces presynaptically the release of several neurotrans- bicuculline (Wang et al., 1994). These data indicated mitters, including the excitatory amino acid, L-gluta- that NO is an endogenous anticonvulsant substance. mate (Montague et al., 1994). This indicates that NO All NO synthase inhibitors used in these studies are deranges the neurotransmitter balance in the central alkyl esters of arginine and affect both neuronal NO nervous system (CNS) and affects neuronal excitability.
    [Show full text]
  • Basic Analytical Toxicology
    The World Health Organization is a specialized agency of the United Nations with primary responsibility for international health matters and public health. Through this organization, which was created in 1948, the health professions of some 190 countries exchange their knowledge and experience with the aim of making possible the attainment by all citizens of the world by the year 2000 of a level of health that will permit them to lead a socially and economically productive life. By means of direct technical cooperation with its Member States, and by stimulating such coopera­ tion among them, WHO promotes the development of comprehensive health services, the prevention and control of diseases, the improvement of environmental conditions, the development of human resources for health, the coordination and development of biomedical and health services research, and the planning and implementation of health programmes. These broad fields of endeavour encompass a wide variety of activities, such as developing systems of primary health care that reach the whole population of Member countries; promoting the health of mothers and children; combating malnutrition, controlling malaria and other communicable diseases including tuberculosis and leprosy; coordinating the global strategy for the prevention and control of AIDS; having achieved the eradication of smallpox, promoting mass immunization against a number of other preventable diseases; improving mental health; providing safe water supplies; and training health personnel of all categories. Progress towards better health throughout the world also demands international cooperation in such matters as establishing international standards for biological substances, pesticides and pharma­ ceuticals; formulating environmental health criteria; recommending international nonproprietary names for drugs; administering the International Health Regulations; revising the International Statistical Classification of Diseases and Related Health Problems and collecting and disseminating healih statistical information.
    [Show full text]